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Clinical interventions that increase the uptake or success of vaginal birth after 
caesarean section: a quantitative systematic review 
 
Abstract 
Aim 
To review clinical interventions that increase the uptake and/or the success rates of vaginal 
birth after caesarean section. 
Background 
Repeat caesarean section is the main reason for the increase in surgical births. The risk of 
uterine rupture in women who have prior caesarean sections prevents many clinicians from 
recommending vaginal birth after caesarean. Despite this, support for vaginal birth after 
caesarean continues.  
Data Sources 
A search of five databases and a number of relevant professional websites was undertaken up 
to December 2008. 
Review methods 
A systematic review of quantitative studies that involved a comparison group and examined a 
clinical intervention for increasing the uptake and/or the success of vaginal birth after 
caesarean section was undertaken. An assessment of quality was made using the Critical 
Skills Appraisal Programme. 
Results 
Induction of labour using artificial rupture of membranes, prostaglandins, oxytocin infusion 
or a combination, was associated with lower vaginal birth rates. Cervical ripening agents such 
as prostaglandins and transcervical catheters may result in lower vaginal birth rates compared 
with spontaneous labour. The impact of epidural anaesthesia in labour on vaginal birth after 
caesarean success is inconclusive. X-ray pelvimetry is associated with reduced uptake of 
vaginal birth after caesarean and higher caesarean section rates. Scoring systems to predict 
likelihood of vaginal birth are largely unhelpful. There is insufficient data in relation to 
vaginal birth after caesarean success between different closure methods for the primary 
caesarean section. 
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Conclusion 
Clinical factors can affect vaginal birth after caesarean uptake and success. 
 
Keywords: Vaginal birth after caesarean section, caesarean section, systematic review, 
literature review, Hospitals, maternity, intervention studies 
Summary statement 
What is already known about this topic? 
 There is a high caesarean section rate around the world, and a high proportion of this is 
women electing to have an elective repeat caesarean. 
 There is considerable variation in regard to acceptance, uptake, support and success of 
women undergoing VBAC. 
What this paper adds  
 Induction of labour using artificial rupture of membranes, prostaglandins, oxytocin 
infusion and various combinations of these methods, is often associated with a lower 
VBAC success rate.  
 Cervical ripening agents such as prostaglandins and transcervical Foley catheters may 
result in a lower VBAC success rate compared with women who labour spontaneously. 
 Women who have x-ray pelvimetry have a reduced uptake of VBAC, and higher 
caesarean section rates.  
 Scoring systems devised to predict VBAC success are largely unhelpful. 
Implications for practice and/or policy: 
 Clinicians need to show caution when inducing or augmenting women who have had a 
previous caesarean section. 
 X-ray pelvimetry and scoring systems to predict VBAC success should not be used 
exclusively to direct clinical practice. 
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Introduction 
 
Many women opt for repeat caesarean after a primary caesarean section (CS) (Thomas and 
Paranjothy 2001; Guise, McDonagh et al. 2003). Rates of vaginal birth after caesarean section 
(VBAC) vary, for example 16.6% in Australia and 33% in the UK (Thomas and Paranjothy 
2001; Laws, Grayson et al. 2006). In the United States of America (USA), a large study found 
women attempting a vaginal birth after a prior CS had at least a 73% likelihood of success 
(Landon, Hauth et al. 2004). The United Kingdom (UK) National Sentinel Caesarean Section 
Audit demonstrated variation between units of 6 to 64% (Thomas and Paranjothy 2001). 
Possible reasons behind the low uptake and success of VBAC include women’s fear of 
uterine rupture in a subsequent labour and birth; health care provider fears of offering any 
choice other than a repeat caesarean; fear of litigation, and convenience, amongst others. 
Caesarean section has also been demonstrated in Australia as a preferred, safe and ‘ordered’ 
option in discourses with women (Bryant, Porter et al. 2007). Nonetheless, other studies have 
a found that a trial of labour is cost-effective (as opposed to an elective CS) and provides a 
higher quality of life (Traynor and Peaceman 1998; Guise, McDonagh et al. 2003).   
 
Maternal preference is undoubtedly a factor in the rising rates of CS (Kerr-Wilson 2001). 
Women often fear the pain of a vaginal birth (Weaver, Statham et al. 2007), have concerns 
regarding the safety of their babies (Villar, Carroli et al.), postpartum sexual function  (Lin 
and Xirasagar 2005)  and may perceive an inadequacy of care (McCourt, Weaver et al. 2007). 
A UK study found only a few women request a caesarean in the absence of clinical 
indications, although maternal request was perceived by obstetricians to be a major factor in 
driving the CS rate (Weaver, Statham et al. 2007). The same study found women’s 
psychological issues and perceptions of risk were significant factors in many maternal 
requests for repeat CS.   
 
Caesarean section poses significant short and long term risks to both women and babies 
(Morrison, Rennie et al. 1995; MacDorman and Singh 1998; Smith, Pell et al. 2004; Villar, 
Valladres et al. 2006; Ritcher, Bergmann et al. 2007). Women have a greater risk of 
morbidity and mortality when having a caesarean section compared with a vaginal birth 
(Lydon-Rochelle, Holt et al. 2000; Lumbiganon, Laopaiboon et al. 2010). Lydon-Rochelle et 
al., (2000) found women who had CS were significantly more likely to be readmitted to 
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hospital for uterine infection, obstetrical surgical wound complications, and cardiopulmonary 
and thromboembolic conditions.  
 
We have undertaken an extensive review of the literature (Catling-Paull, Johnstone et al. 
2010) as there are no systematic reviews specifically addressing the promotion or success of 
VBAC. Studies reporting interventions designed to promote the uptake or success of VBAC 
were identified and evaluated. They broadly fell into two categories, that is, clinical and non-
clinical interventions. This paper reports the clinical interventions.  
 
Method of review 
 
Aim 
The aim of this review was to identify the clinical interventions that increase the success 
and/or uptake of VBAC. These interventions can occur before, and during, pregnancy and 
during labour.  
 
Design 
A systematic review of quantitative studies was performed using the Cochrane guidelines for 
a systematic review (Higgins and Green 2009) with particular variations. These involved the 
inclusion of a greater range of studies than solely randomised controlled trials (RCT).  
 
Search methods 
The PICO principles (population, intervention, comparison and outcome) were used to 
formulate clinical questions that guided the search strategy. The questions were: What is the 
uptake and success rates of VBAC (O) for women who have had a previous caesarean section 
(P) comparing a range of interventions (I) compared with no intervention or different 
interventions (C). Essentially, we were interested in what makes a difference to the VBAC 
uptake and success rates.  
 
An unrestricted search of CDSR (Cochrane Database of Systematic Reviews), CINAHL 
(Cumulative Index to Nursing & Allied Health), Ovid MEDLINE(R), MIDIRS (Maternity 
and Infant Care), and PsycINFO was undertaken to determine any studies that evaluated an 
intervention for VBAC. Government health websites and obstetric and midwifery 
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professional organisation websites were searched. Reference lists of relevant articles, 
including any guidelines and reviews, were also examined. The inclusion criteria was all 
studies written in English that evaluated an intervention for increasing either the uptake of 
and/or the success of VBAC; involved a comparison group (randomised controlled trials, 
cohort studies, case control studies and before and after studies); and, published up to 
December 2008. Studies that did not report VBAC uptake or success rates were excluded. 
Only primary sources were considered appropriate for this review. Systematic reviews were 
used to source further publications but were excluded as they were not primary sources.  
 
Keywords used: “Intervention” and “Pregnancy Outcome” with “Vaginal Birth After 
C(a)esarean/Caesarian”, “VBAC”, “Trial of Labo(u)r “, “C(a)esarean/Caesarian Section”, and 
“C(a)esarean/Caesarian Section, repeat”.  
 
Quality appraisal 
Studies were rated using the Critical Appraisal Skills Programme (CASP) (Public Health 
Resource Unit, 2007). CASP is a specifically developed, internationally-used, critical 
appraisal tool, designed to encourage an evidence-based approach to health and social care. 
Quality scores for the cohort studies were: <5 – Poor, 6-9 – Fair, and 10-12 – Good. A similar 
grading out of 10 points was given for the randomised controlled trials. Studies deemed poor 
were evaluated by a second reviewer to confirm the rating and thus their exclusion. This 
resulted in two studies moving from poor to fair. Finally, 31 studies were deemed ‘good’, 30 
‘fair’ and 17 ‘poor’. Hence, there were 61 included studies rated as ‘good’ or ‘fair’. Of these, 
27 addressed non-clinical interventions and 34 addressed clinical interventions (Figure 1). 
The 34 studies reporting clinical interventions are reviewed in this paper.  
 
Data abstraction and synthesis 
Data were extracted by three independent reviewers. After the search, studies reporting 
clinical interventions were grouped by study intervention which identified eight major 
categories to increase the uptake and/or success of VBAC. A narrative summary was then 
undertaken to report the findings. A meta-analysis was not undertaken due to the 
heterogeneity and insufficient number of studies. 
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Most studies provided limited statistical details. Many only reported p-values, rather than 
95% confidence intervals. Despite this, these studies were included as excluding them would 
have severely limited the review.  
 
Findings 
 
Thirty-four papers were identified that met the inclusion criteria. This included six 
randomised controlled trials (RCT) testing clinical interventions for increasing VBAC uptake 
or success. There were 18 retrospective and 10 prospective cohort studies (Table 1).  
 
The main categories were induction/augmentation of labour, the use of imaging (e.g. X-ray), 
evidence-based criteria (e.g. scoring systems), closure of primary CS, and epidural use in 
labour. After CASP rating, the studies in the categories of partograms and cervical dilation 
patterns, ultrasonography, and waterbirth were excluded as no studies met the inclusion and 
quality criteria. These are not discussed further.  
 
Induction / augmentation of labour  
The induction and augmentation of labour category had the largest number of studies. Six 
studies were excluded after a poor CASP rating (Horenstein, Eglinton et al. 1984; Lao and 
Leung 1987; Chua, Arulkumaran et al. 1989; Coltart, Davies et al. 1990; Sakala, Kaye et al. 
1990; Ben-Aroya, Hallak et al. 2002) which left 18 studies. This category was sub-classified 
into Prostaglandin use / cervical ripening, Induction of labour (various methods), Oxytocin 
use (IOL or augmentation), and Other methods. Uptake rates of VBAC are not assessed in 
these studies as all studies compared either, methods of augmentation or induction to one 
another, or to women in spontaneous labour. VBAC success rate is the reported outcome of 
interest within this category.  
 
Prostaglandin use / cervical ripening 
The use of cervical ripening agents was tested in two RCTs (Taylor, Sellers et al. 1993; 
Rayburn, Gittens et al. 1999) and five cohort studies (Blanco, Collins et al. 1992; Flamm, 
Anton et al. 1997; Bujold, Blackwell et al. 2004; Hoffman, Sciscione et al. 2004; Yogev, 
Ben-Haroush et al. 2004).  
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Rayburn and others (1999) randomised 294 women to either receive a weekly dose of 0.5mg 
intracervical prostaglandin E2 gel from 39 to 41 weeks or be managed expectantly. Oxytocin 
was used in both groups for augmentation or induction as needed after 41 weeks. There was 
no difference in VBAC rates with a rate of 49 percent in both intervention and expectant 
groups. Taylor et al. (1993) randomised 42 women to receive either vaginal prostaglandin E2 
(PGE2) followed by amniotomy three hours later or amniotomy and intravenous oxytocins. 
Women had been advised to have an induction of labour due to pre eclampsia or post dates 
pregnancy. This trial found no differences in the rate of VBAC. One woman from the 
prostaglandin group had a uterine rupture.  
 
Most of the cohort studies compared different cervical ripening agents (Blanco, Collins et al. 
1992; Flamm, Anton et al. 1997; Hoffman, Sciscione et al. 2004; Yogev, Ben-Haroush et al. 
2004), or Foley catheter (Bujold, Blackwell et al. 2004; Hoffman, Sciscione et al. 2004) to 
spontaneous labour. Two of these showed no difference in VBAC rates between the groups 
(Blanco, Collins et al. 1992; Yogev, Ben-Haroush et al. 2004), but both had small numbers of 
women who received PGE2. Three cohort studies demonstrated that spontaneous labour was 
associated with a higher VBAC success rate than women who had undergone cervical 
ripening (Flamm, Anton et al. 1997; Bujold, Blackwell et al. 2004; Hoffman, Sciscione et al. 
2004). Success rates for women who underwent cervical ripening ranged from 46% 
(Hoffman, Sciscione et al. 2004) to 56% (Bujold, Blackwell et al. 2004).  
 
Induction of labour (various methods) 
Four cohort studies assessed whether or not induction of labour (IOL) affected VBAC rates. 
IOL methods included artificial rupture of membranes (ARM), prostaglandins, oxytocin 
infusions and combinations of these methods. The studies grouped women into ‘induction of 
labour’ and compared them with those who laboured spontaneously (Rageth, Juzi et al. 1999; 
Sims, Newman et al. 2001; Delaney and Young 2003), whilst one study compared three 
different methods of induction (Pathadey, Van Woerden et al. 2005).  
 
Three of the four studies comparing IOL with spontaneous labour reported that induction was 
associated with a lower VBAC success rate (Rageth, Juzi et al. 1999; Sims, Newman et al. 
2001; Delaney and Young 2003). The largest of these studies was by Rageth et al. (1999) and 
included 17,613 women, 2,459 of whom were induced. The VBAC success rate for women 
undergoing IOL was 66% compared with 75% in women who laboured spontaneously.  
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One study compared three different methods of inducing labour: ARM, oxytocin infusion and 
prostaglandins (Pathadey, Van Woerden et al. 2005). The study was small, only 81 women in 
total, with three receiving oxytocin. No findings reached statistical significance although 
there was a trend towards higher rates of successful VBAC in women who had undergone an 
ARM for IOL (with or without oxytocin) compared with those who received prostaglandins.  
 
Oxytocin use 
Five cohort studies addressed the use of oxytocin for either IOL or augmentation. One study 
(Flamm, Newman et al. 1990) grouped all women who received oxytocin regardless of the 
indication and compared them with women who did not receive oxytocin. Flamm et al. 
(1990) included 5733 women attempting VBAC, of whom 1686 received oxytocin for either 
IOL or augmentation. The proportion of IOL versus augmentation was not specified. VBAC 
success was lower in the oxytocin group (68%) compared with the no-oxytocin group (78%), 
although rates in both groups was high.  
 
Of the remaining studies, an earlier study by Flamm et al. (1987) has the largest number of 
participants, with 405 women in the oxytocin group (149 for IOL) and 1291 women who did 
not receive oxytocin. Women who received oxytocin at 3-4cm cervical dilatation had a 72% 
VBAC success rate, and those who received oxytocin at 5-10cm had a 64% success rate. 
These two groups were not significantly different from one another, but both were different 
from the IOL group.  
 
The remaining four studies have varying results. Horenstein et al. (1985) showed no 
difference in success rates for women who had oxytocin IOL (72% of 32 women) compared 
with augmentation (69% of 257 women). When all women receiving oxytocin were included, 
success rates were lower than women who did not receive oxytocin (89% of 443 women).  
 
Stronge et al. (1996) included 13 women who were induced by oxytocin and 75 who were 
augmented. Due to the low IOL numbers, only augmentation rates were reported and 
compared with 120 women who did not receive oxytocin. Women receiving oxytocin 
augmentation were less likely to achieve VBAC (63% vs 86%).  
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In contrast to other studies in this category, Lai and Sidek (1993) reported higher rates of 
successful VBAC in the presence of oxytocin. There were small numbers in this study, but 
58% of the 66 women who had spontaneous labour without augmentation had a VBAC rate. 
The VBAC rate was 77% in the 22 women who had a spontaneous labour augmented with 
oxytocin, The VBAC rate in the 11 women induced with oxytocin was 82%.  
 
There were no differences in the maternal and neonatal morbidity or mortality outcomes in 
the studies that reported oxytocin use. The outcomes included uterine rupture, neonatal 
mortality, Apgar scores, maternal haemorrhage, hysterectomy, and perineal lacerations 
(Horenstein and Phelan 1985; Flamm, Goings et al. 1987; Flamm, Newman et al. 1990; Lai 
and Sidek 1993). These studies were underpowered to assess adverse outcomes such as 
uterine rupture. 
 
Other methods 
A number of other IOL methods have been studied. Lelaidier et al. (1994) randomised 32 
women to either receive 200mg of mifepristone or placebo over a four day period. 
Mifepristone is a synthetic steroid used for the induction of labour. Induction of labour was 
planned for all women at the end of the four days as needed. The VBAC rates were 69% for 
the mifepristone group and 50% for controls which was not statistically significantly different 
given the small sample size. 
 
In the USA, Grubb et al. (1996) tested the efficacy of early augmentation of labour in women 
with ineffective contractions. Women randomised to the intervention group were admitted to 
hospital and received the usual care for women undertaking trial of labour with unknown 
uterine scars. The control group ambulated and if no cervical change or spontaneous rupture 
of membranes had occurred after four hours, the woman was discharged with instructions to 
return for increasing contractions, rupture of membranes, vaginal bleeding, or decreased fetal 
movement. There were no statistically significant differences in VBAC rate (84% for the 
intervention group and 83% for the control group). There were five cases of uterine scar 
separation in the intervention group and none in the control group.  
 
Use of Imaging (MRI, X-ray, CT)  
Imaging such as MRI, X-ray or CT to evaluate the ‘adequacy’ of the maternal pelvis was 
evaluated. Most studies used imaging on all women and categorised them according to pelvic 
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dimensions. Twelve studies were initially identified. Following CASP rating, five were 
excluded (Wright 1985; Lao, Chin et al. 1987; Lau, Leung et al. 1998; Fox, Huerta-Enochian 
et al. 2004; Sibony, Alran et al. 2006) leaving seven studies. 
 
All women undergo imaging 
Five studies (Ngu and Quinn 1985; Mahmood and Grant 1987; Krishnamurthy, Fairlie et al. 
1991; Thurnau, Scates et al. 1991; Wong, Wong et al. 2003) included women who all 
underwent imaging in pregnancy and compared groups of women (e.g. ‘adequate’ vs 
‘inadequate’). Definitions of pelvic adequacy differed between studies, but the authors’ 
definitions have been used. Studies that assessed uptake of VBAC showed a reduction in the 
number of women attempting VBAC following classification of ‘inadequate’ pelvis 
(Mahmood and Grant 1987; Krishnamurthy, Fairlie et al. 1991). In one study 
(Krishnamurthy, Fairlie et al. 1991), VBAC uptake rates for women with an ‘inadequate’ or 
‘adequate’ pelvis were 27% and 95%, respectively. Other authors advised women with an 
‘inadequate’ pelvis to have an elective CS even if they fulfil the criteria for VBAC (Abu-
Ghazzeh and Barqawi 2000). Three studies reported no difference in VBAC success rates 
related to pelvic adequacy (Ngu and Quinn 1985; Mahmood and Grant 1987; Krishnamurthy, 
Fairlie et al. 1991).   
 
Imaging vs no-imaging 
Three studies compared women who underwent imaging in pregnancy compared with those 
who did not (Mahmood and Grant 1987; Thubisi, Ebrahim et al. 1993; Abu-Ghazzeh and 
Barqawi 2000). Thubisi et al. conducted the only RCT involving 288 women. Women in the 
control group had standard antenatal care which included a clinical pelvic assessment and a 
postpartum X-ray pelvimetry (XRP). Of the 144 women in the intervention group, 84 were 
considered to have an adequate pelvis on XRP and 23 of these gave birth vaginally (28%). 
Women considered on antepartum XRP to have an inadequate pelvis had a CS. Of the 144 
women in the control group, 44% gave birth vaginally. In the control group, 33 of the 60 
women (55%) who had a vaginal birth were assessed to have an ‘inadequate pelvis’ based on 
postpartum XRP and would have had a CS if this information had been known antenatally. 
This trial provides strong evidence that XRP is a poor predictor of VBAC success and might 
increase CS rates.  
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Other studies show a similar lack of benefit. Mahmood et al., (1987) in a retrospective cohort 
study of 239 women, found no differences in VBAC rates between those with imaging and 
those without. Within the imaging group, women with an ‘adequate’ pelvis were more likely 
to attempt VBAC than those with an ‘inadequate’ pelvis (as discussed above). A study of 219 
women by Abu-Gazzeh et al. (2000) demonstrated that imaging in pregnancy had a negative 
effect on the uptake of VBAC. All women in the study initially had a preference for VBAC, 
however, 23% of women in the pelvimetry group were told they had an ‘inadequate’ pelvis 
and had a repeat CS. This led to an overall VBAC rate of 49% in the pelvimetry group 
compared with 78% in the group who did not have pelvimetry. The VBAC success rate in the 
pelvimetry group was also lower (64% vs 78%). 
 
Using evidence-based criteria  
This category examined five studies testing evidence-based criteria, such as tools, for 
predicting the success of VBAC. Three reported on the outcome of a scoring system for 
predicting VBAC success (Flamm and Geiger 1997; Vinueza, Chauhan et al. 2000; Hashima 
and Guise 2007). All these used different scoring tools and were retrospective assessing 
women who had attempted VBAC.  
 
The first by Vinueza et al. (2000), assessed the ability of a scoring system designed by Troyer 
and Parisi (1992) to predict VBAC success. There was an inverse relationship between the 
score and successful VBAC. That is, women who scored 0 (a previous vaginal birth, CS was 
not for dysfunctional labour, no induction required and reassuring fetal heart rate) had a 98% 
chance of successful VBAC. Women with a score of 1 had a 69% success rate; a score of 2 
had a 40% success rate; and a score of 3 had a 33% chance of achieving VBAC.  
 
Hashima et al. (2007) and Flamm et al. (1997) employed similar techniques. Each tested a 
newly developed scoring system on a different cohort of women attempting VBAC. Hashima 
et al. found that non-recurrent prior caesarean indication, no history of a macrosomic infant, 
and no current maternal anaemia were associated with VBAC, and assigned women a score of 
1 for each criteria they fulfilled. A linear relationship between score and VBAC success was 
seen, with success rates of 25%, 49%, 53% and 67% for scores 0, 1, 2 and 3 respectively. 
Flamm et al. determined five factors to be associated with successful VBAC in women who 
chose a trial of labour. These were less than 40 years, previous vaginal birth, CS for reasons 
other than failure to progress, cervical effacement at admission and cervical dilation of 4cm 
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or more at admission. Again, a linear relationship was noted between the score and the 
likelihood of successful VBAC. Women who scored 0-2 had a 49% chance of VBAC, 
compared with 95% in those who scored 8-10.  
 
Another study (Bujold, Blackwell et al. 2004) examined the usefulness of a modified version 
of the commonly used Bishop’s score to predict the success of IOL in women with a previous 
CS. Participants were categorised into four groups depending on their modified Bishop’s 
score. The study demonstrated a linear relationship between the modified Bishop’s score and 
successful VBAC. Women in the lowest category had a VBAC rate of 58% compared with 
97% in the highest.  
 
Finally, Pickhardt (1992) examined 19 variables to determine women’s likelihood of a 
successful VBAC. He concluded that almost all women should attempt a VBAC, and that 
there were very few predictive factors of successful or unsuccessful VBAC that could be used 
to enhance the care of women. 
 
Closure of primary CS  
One RCT (Chapman, Owen et al. 1997) and two retrospective cohort studies (Durnwald and 
Mercer 2003; Gyamfi, Juhasz et al. 2006) examined the effect of the closure of the primary 
CS wound on future VBAC success. The RCT was a follow up study of an original trial 
conducted to examine the short term effectiveness of closure using one versus two layers of a 
locking suture in a CS (Hauth, Owen et al. 1992). Four years after the original study, 164 
women from the original sample who had had a subsequent birth at the study institution were 
identified (Chapman, Owen et al. 1997). The 83 women who had had one layer closure were 
similar to the 81 women who had had two layer closure and there were no significant 
differences in the VBAC rate.  
 
The two retrospective cohort studies included large numbers of women (948 and 768) but 
only a small proportion in each study had single layer uterine closure (35 and 267, 
respectively). Neither studies found a difference in VBAC uptake or success between single 
and double layer closure of the primary CS.  
 
Epidural use in labour  
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Two studies were identified that used epidural analgesia in labour as an intervention. One was 
excluded after CASP rating (Sakala, Kaye et al. 1990). The remaining study assessed the use 
of epidural analgesia in labour on VBAC success (Stovall, Shaver et al. 1987). Stovall et al. 
(1987) conducted a prospective cohort study of 272 women and found that VBAC success 
was less in women who used an epidural in labour (74.5%) compared with those who did not 
(85.7%), however rates were high in both groups.  
 
Discussion 
 
A number of clinical interventions evaluated appear to be effective in increasing either the 
uptake or success rates of VBAC. A large number of studies regarding clinical interventions 
for VBAC examined IOL or augmentation of labour, using various methods. The majority 
showed that women who require induction or augmentation were likely to have a lower 
chance of VBAC success than women who labour spontaneously. However, in most cases, 
the success rates in both groups were still high. Although this is a useful comparison to make, 
it does not provide detailed information on how induction or augmentation affects VBAC 
outcomes. There are many confounding variables that will impact these results. Women who 
require IOL or augmentation are probably less likely to proceed to a vaginal birth as there are 
other factors influencing their labour apart from the use of chemical agents to begin or 
improve labour. A more useful comparison to determine the effects of inducing or 
augmenting agents on women having a VBAC would be to compare women with labour 
dystocia who were given oxytocin to women with labour dystocia who were not given 
oxytocin. Changing the comparison group would give a more accurate indication of the 
effects of oxytocin in labour for women with labour dystocia rather than comparing them 
with women who did not experience labour dystocia. Whether or not it would be ethical to 
conduct this type of research is debatable.  
 
It is not surprising that cervical ripening agents such as prostaglandins and transcervical Foley 
catheters may result in a lower VBAC success rate compared with women who labour 
spontaneously. For women without a previous CS, cervical ripening and induction of labour 
are associated with a reduction in the chance of vaginal birth (Alfirevic, Kelly et al. 2009). 
Although the chances of vaginal birth may be lower for women who undergo cervical 
ripening, the success rate is still around 50% or greater. Cervical ripening may provide a 
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means of avoiding a number of unnecessary caesarean sections for women with a previous 
CS however, this study did not aim to address the safety concerns around the use of 
prostaglandins in these women. Certainly, there are other factors involved in the decision to 
attempt cervical ripening techniques for women with a previous CS.  
 
Given that all included studies in the induction/augmentation category compared women 
undergoing IOL or augmentation with those who laboured spontaneously, it is no surprise 
that rates of VBAC success appear lower. However, if the clinical decision making involves 
the trial of an inducing or augmenting agent or having a repeat CS then it seems reasonable 
that induction or augmentation may increase VBAC. Considering that success rates across 
studies of IOL or augmentation are 50% or greater, it seems reasonable that women 
attempting a VBAC be assessed for the appropriateness of these agents, if needed. What this 
study does not address is the safety of induction or augmentation for women attempting 
VBAC. Issues such as a potential increase in uterine rupture rates with induction agents such 
as prostaglandins have not been included. Other studies have addressed this, for example a 
systematic review by Guise et al. (2003) reports a 10 percent reduction in normal birth after 
oxytocin use and a similar reduction after the use of prostaglandins and McDonagh et al 
(2005) reports a non-significant increase in uterine rupture in women with previous caesarean 
sections whose labours were induced. 
 
The same is true of epidural use in labour. Although it is important to ensure that women are 
aware that the use of epidural may reduce their likelihood of having a successful VBAC, 
there are likely a number of confounding variables involved and perhaps differences between 
the labours of women who choose an epidural and those who do not. These factors may 
impact the outcome more significantly than the use of epidural alone. In women without a 
previous CS, epidural use is associated with a higher likelihood of instrumental delivery, so it 
is not surprising that epidural use during VBAC may be associated with a lower success rate.  
 
The available evidence does not indicate which clinical factors may increase VBAC uptake or 
success rates. The use of imaging in pregnancy to assess pelvic adequacy appears to increase 
clinician and maternal anxiety, reducing VBAC uptake and preventing a proportion of women 
who may have achieved a vaginal birth from even attempting. The correlation between pelvic 
adequacy and VBAC success is not strong, and recommendation of its use appears unethical 
given the significant proportion of women with a pelvis deemed to be ‘inadequate’ who 
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achieve a VBAC. Furthermore, other predictive tools such as scoring systems with respect to 
risk factors or the study of the cervicogram from the previous labour may facilitate decision 
making (particularly for women who have a very high probability of successful VBAC using 
these tools) but may also increase anxiety for women in the group with the poorest outcome. 
The clinical value of such scoring systems is limited.  
 
It was not possible to undertake a meta-analysis on these data and this is a limitation of this 
review. There is significant heterogeneity of management techniques and inclusion criteria 
for women in the studies that assess hospital factors such as local policies for reducing CS 
rates. In spite of these differences, the literature demonstrates that the attitudes of the 
institution and its clinicians and the desire to reduce CS rates and promote VBAC for women 
with a previous CS can make a significant impact on the uptake and success rates of VBAC. 
This has significant implications for hospital administrators and management staff. A local 
drive and commitment to VBAC from the top down can significantly increase VBAC rates, 
thus lowering the overall CS rate of an institution. High rates of VBAC have been shown to 
be sustainable (Myers and Gleicher 1993). An investment in initiatives to increase the VBAC 
rate may therefore have ongoing returns.  
 
This review provides an important view of the literature in this area however there are 
additional limitations which need to be considered. The findings highlighted a number of 
changes that have occurred in the past two decades. Practices surrounding VBAC have 
changed significantly during the 20 year time span the studies in this review covers. There 
have also been inaccuracies related to ICD-9 codes and data quality during this time period 
(American Medical Association 1995; Reker, Hamilton et al. 2001), and as such, studies 
using these codes in their methods may be flawed. Our review included all studies with a 
comparison group and as such bias could have been introduced. Typically, systematic reviews 
only select RCTs if the aim is to determine effectiveness. As the number of RCTS is small 
and some aspects of this do not lend themselves to random allocation, we felt the review 
would be limited if we chose this path. Therefore, to incorporate a greater range of studies we 
chose any study with a comparison group that met the other inclusion criteria.  
 
Conclusion 
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Induction of labour using ARM, prostaglandins, oxytocin infusion and various combinations 
of these methods, is often associated with a lower VBAC success rate. The use of oxytocin 
appears to be safe but may decrease the number of women achieving VBAC. Cervical 
ripening agents such as prostaglandins and transcervical Foley catheters may result in a lower 
VBAC success rate compared with women who labour spontaneously. Evidence on whether 
epidural use in labour contributes to VBAC success is insufficient. 
 
Women who have X-ray pelvimetry have a reduced uptake of VBAC, and higher caesarean 
section rates, and as such, X-ray pelvimetry is a poor predictor of the outcome of a trial of 
labour. Similarly, scoring systems devised to predict VBAC success are mostly unhelpful, 
although some large-study systems have some clinical value. There is insufficient data to 
comment on differences in rates of VBAC success between different methods of closure of 
the primary caesarean section. 
 
Future research needs to address the implementation and testing of effective interventions to 
increase the uptake and success of VBAC. This review provides valuable information that 
will assist clinicians, researchers and policy makers in their future endeavours to address this 
important issue.  
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Figure 1: A flowchart of excluded and included studies 
 
Non-Clinical interventions= practices indirectly affecting women’s VBAC uptake/success (e.g. hospital 
guidelines)  
Clinical interventions= practices directly affecting women’s VBAC uptake/success (e.g. induction of 
labour methods) 
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Table 1: Details and CASP rating of included studies by category area 
 
 
Trial (author and date) Country  Design CASP rating 
Induction / augmentation of labour (n=18) 
Prostaglandin use / cervical ripening 
Taylor et al 1993 UK RCT FAIR 
Rayburn et al 1999 USA RCT GOOD 
Flamm et al. 1997 USA Prospective cohort GOOD 
Blanco et al. 1992 USA Prospective cohort FAIR 
Yogev et al 2004 Israel Retrospective cohort FAIR 
Hoffman et al 2004 USA Retrospective cohort GOOD 
Bujold et al. 2004a Canada Retrospective cohort GOOD 
 Induction of labour (various methods) 
Sims et al. 2001 USA Prospective cohort FAIR 
Delaney & Young, 2003 Canada Retrospective cohort GOOD 
Rageth et al. 1999 Switzerland Retrospective cohort GOOD 
Pathadey et al. 2005 UK Retrospective cohort FAIR 
 Oxytocin use 
Flamm et al. 1987 USA Retrospective cohort GOOD 
Flamm et al. 1990 USA Prospective cohort FAIR 
Lai and Sidek 1993 Singapore Retrospective cohort FAIR 
Stronge et al. 1996 Ireland Prospective cohort study FAIR 
Horenstein et al. 1985 USA Prospective cohort FAIR 
 Other methods 
Grubb and Kjos 1996 USA RCT FAIR 
Lelaidier et al 1994 France RCT GOOD 
Imaging (MRI, X-ray, CT) (n=7) 
Thubisi et al 1993 South Africa RCT GOOD 
Krishnamurthy et al. 1991 Scotland Retrospective cohort FAIR 
Mahmood et al. 1987 UK Retrospective cohort FAIR 
Ngu et al 1985 Australia Retrospective cohort FAIR 
Thurnau et al. 1991 USA Prospective cohort GOOD 
Wong et al. 2003 China Prospective cohort GOOD 
Abu-Ghazzeh et al. 2000 Jordan Prospective cohort FAIR 
Evidence-based criteria (n=5) 
Hashima et al. 2007 USA Retrospective cohort GOOD  
Pickhardt et al. 1992 USA Retrospective cohort FAIR  
Vinueza et al 2000 USA Retrospective cohort  FAIR 
Flamm and Geiger 1997 USA Retrospective cohort GOOD 
Bujold et al. 2004b Canada Retrospective cohort GOOD 
Closure of primary CS (n=3) 
Chapman et al 1997 USA RCT  FAIR 
Gyamfi et al. 2006 USA Retrospective cohort GOOD 
Durnwald and Mercer 2003 USA Retrospective cohort GOOD 
Epidural analgesia / anaesthesia (n=1) 
Stovall et al. 1987 USA Prospective cohort FAIR 
23 
 
Table 2: Detailed information on induction/augmentation of labour studies 
Trial 
(author 
and date) 
Intervention Sample size and 
comparison group 
Uptake of 
VBAC 
Impact on VBAC success 
rates 
Statistical 
values 
       Prostaglandin use / cervical ripening 
Taylor et al 
1993 
PGE2 and 
amniotomy vs 
oxytocin and 
amniotomy 
42 women 
 21 PGE2 
 21 Oxytocin 
NA No difference  
 
p=NS 
Rayburn et 
al 1999 
Weekly 
intracervical PGE2 
294 women 
 143 PGE2 
 151 Expectant 
NA No difference  
 
p=NS 
Flamm et 
al. 1997 
PGE2 IOL 5022 women  
 453 PGE2 
NA 77% - no PGE2 
 51% - PGE2  
 
p=0.0001 
Blanco et 
al. 1992 
PGE2 IOL 81 women 
 25 PGE2 
NA No difference 
 
p=NS 
Yogev et al 
2004 
PGE2 IOL 1028 women 
 931 spontaneous 
labour  
 97 PGE2 
NA No difference NR 
Hoffman et 
al 2004 
Preinduction 
cervical ripening – 
misoprostol, PGE2 
Foley catheter 
934 women  
 398 with cervical 
ripening 
NA 77% VBAC without 
intervention 
 47% VBAC with intervention 
 
p=0.001 
Bujold et 
al. 2004a 
Amniotomy Foley 
catheter 
spontaneous labour 
2479 women 
 417 amniotomy 
 255 Foley catheter  
 1807 spontaneous 
labour 
NA 78%  VBAC with amniotomy 
56% VBAC with Foley 
Catheter  
78% VBAC with spont. labour  
p <0.01 
Foley v 
control 
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       Induction of labour (various methods) 
Sims et al. 
2001 
IOL – oxytocin, 
misoprostol, 
dinoprostone 
236 women  
 179 spontaneous 
labour 
 57  IOL 
NA 77% - VBAC with 
spontaneous labour 
58% - VBAC with IOL 
p=0.008 
Delaney & 
Young, 
2003 
IOL 3746 women 
 2943 spontaneous 
labour 
 803 IOL 
NA 75.8% - VBAC with 
spontaneous labour 
 62.5% - VBAC with IOL  
p<0.001 
Rageth et 
al. 1999 
IOL 17,613 women  
 15,154 spontaneous 
labour 
 2459 IOL  
NA 75% VBAC with no IOL 
66% VBAC with IOL 
NR 
Pathadey 
et al. 2005 
IOL – 
amniotomy 
oxytocin  
PGE2 
81 women 
 36 amniotomy 
 5 amniotomy and 
oxytocic 
 34 PGE2 
 3 oxytocic only 
NA 79% - VBAC 
No difference 
p=NS 
    Oxytocin use 
Flamm et 
al. 1987 
Oxytocin for IOL 
or augmentation 
1776 women 
 485 oxytocin 
 1291 no oxytocin 
NA 78% VBAC without oxytocin  
64% VBAC with oxytocin 
 
p<0.001 
Flamm et 
al. 1990 
Oxytocin  5733 women  
 1686  oxytocin  
 4047 no oxytocin 
NA 78% VBAC without oxytocin 
68% VBAC with oxytocin 
p<0.001 
Lai and 
Sidek 1993 
Oxytocin for IOL 
or augmentation 
99 women 
 66 spontaneous 
labour, without 
oxytocin 
 22  oxytocin 
 11 IOL plus oxytocin 
NA 58% VBAC with spontaneous 
labour  
77% VBAC with oxytocin 
82% VBAC with IOL 
p<0.05 
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Note: The statistics are presented as they were reported in the original publications. Abbreviations: PGE2=Prostaglandin gel,  
CI=Confidence Interval, IOL= Induction of Labour, NS=not significant, NR=Not Reported. 
Stronge et 
al. 1996 
Oxytocin  195 women  
 123 oxytocin not 
used 
 75 oxytocin 
augmentation 
NA 86% VBAC no oxytocin 
63% VBAC with oxytocin 
p=0.001 
Association 
lost on 
multivariate 
analysis 
Horenstein 
et al. 1985 
Oxytocins for IOL 
or augmentation 
732 women 
 443 oxytocin not 
used 
 32 IOL 
 257 augment 
NA 72% - VBAC with IOL 
69% - VBAC with oxytocin  
89% - VBAC with no oxytocin  
p=0.05 
     Other methods 
Grubb and 
Kjos 1996 
Early augmentation 
of labour 
197 women 
 51 no oxytocin 
 78  oxytocin 
NA 77% VBAC with no oxytocin 
80% VBAC with oxytocin 
p=NS 
Lelaidier 
et al 1994 
200mg 
mifepristone 
32 women 
 13 spontaneous 
labour 
 11 mifepristone 
 2 placebo 
NA 69% VBAC with spontaneous 
labour 
37% VBAC with mifepristone 
24% VBAC with placebo 
p=NS 
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Table 3: Detailed information on imaging (MRI, X-ray, CT) studies 
Trial 
(author 
and date) 
Intervention Sample size and 
comparison 
group 
Uptake of VBAC Impact on VBAC success 
rates 
Statistical 
values 
Thubisi et al 
1993 
Antenatal X-ray 
pelvimetry 
228 women 
 84 X-ray 
pelvimetry 
 144 control 
group 
NA 16% - VBAC with x-ray 
pelvimetry 
42%  - VBAC control group 
Pelvimetry is poor predictor 
of the outcome of labour 
OR 3.8, 955 
CI 2.1-6.8 
Krishnamur
thy et al. 
1991 
X-ray pelvimetry 
‘adequate’ vs 
‘inadequate’ 
pelvis 
331 women 
 248 
‘inadequate’ 
pelvis 
 83 ‘adequate’ 
pelvis 
76 women with 
‘inadequate’ pelvis 
and 
79 women with 
‘adequate’ pelvis 
attempted VBAC 
No difference  P=0.11 
Mahmood 
et al. 1987 
X-ray pelvimetry 239 women 
 89 X-ray 
pelvimetry 
 150 control 
group 
within pelvimetry 
group, those with 
‘adequate’ more 
likely to try VBAC 
than those with 
‘inadequate’ 
No difference P<0.01 
 
Ngu et al 
1985 
X-ray pelvimetry 155 women with 
normal X-ray 
pelvimetry 
 93 VBAC 
 62 CS 
NA The larger the pelvic 
diameters, the more likely a 
successful VBAC 
True 
conjugate – 
p<0.002 
Thurnau et 
al. 1991 
 Fetal pelvic 
index vs two 
other methods of 
identifying fetal-
pelvic 
disproportion 
74 women  
 Fetal pelvic 
index 
 Colcher-
Sussman x-ray 
pelvimetry 
NA 72% - VBAC all with 
negative fetal pelvic index 
28% - CS with majority 
having positive fetal pelvic 
index 
The fetal pelvic index was 
p=<0.00001 
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Note: The statistics are presented as they were reported in the original publications. OR=Odds Ratio, CI= Confidence interval.
 Ultrasonograph
y of fetal weight 
over 4gm using 
Shepard tables 
highly predictive of fetal 
pelvic disproportion   
Wong et al. 
2003 
CT-pelvimetry 
positive vs 
negative fetal 
pelvic index 
(positive index= 
fetus larger than 
maternal pelvis) 
170 women 
 57 Repeat CS 
 113 VBAC 
NA 20% - VBAC with positive 
fetal pelvic index  
Fetal pelvic index not 
predictive of outcome of 
attempt for VBAC 
P=0.012 
Abu-
Ghazzeh et 
al. 2000 
CT-pelvimetry 
(use vs no use) 
219 women 
 100 antenatal 
low-dose CT 
pelvimetry 
 119 control 
group 
All women had 
preference for 
VBAC, but 23% in 
pelvimetry group 
told they had 
‘inadequate’ pelvis 
and had elective CS. 
49%  - VBAC with CT 
pelvimetry  
78% - VBAC without  
 
P=0.02 
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Table 4: Detailed information on Evidence-based criteria studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: The statistics are presented as they were reported in the original publications 
Trial 
(author 
and date) 
Intervention Sample size and 
comparison group 
Uptake of 
VBAC 
Impact on VBAC success 
rates 
Statistical 
values 
Hashima et 
al. 2007 
Scoring systems 
 
10828 women   
 Score development 
group 
 Score validation group 
NA  17% - VBAC success if scored 
0 
68% - VBAC success if scored 
3 
NR 
Pickhardt et 
al. 1992 
Factors determined 
that were possibly 
prognostic of CS 
495 women 
 Previous VBAC 
 Previous unsuccessful 
VBAC 
NA 10 predictive factors identified 
significantly related to birth 
outcome   
P=0.05 
Vinueza et 
al 2000 
Scoring system (0-
4) as designed by 
Troyer and Parisi 
263 women  
 Previous dysfunctional 
labour-1 
 No prior vaginal birth-2 
 Non-reassuring FH 
tracing on admission-3 
 Labour induction-4 
NA 98% - VBAC with score of 0 
69% - VBAC with score of 1 
40% - VBAC with score of 2 
33% - VBAC with score 3-4 
Also, increasing CS for CPD 
with increasing scores 
P=<.0001 
Flamm and 
Geiger 
1997 
Scoring system (0-
10) for predicting 
VBAC success 
5003 women  
 Score development 
group 
 Score testing group 
NA Linear relationship between 
scores and success. From 49% 
for score 0-2 to 95% for scores 
8-10 
NR 
Bujold et 
al. 2004b 
Modified Bishop’s 
score for predicting 
IOL success for 
women having 
VBAC 
685 women  
 187 (BS of 0-2) 
 276 (BS of 3-5) 
 189 (BS of 6-8) 
 33 (BS of 9-11) 
NA Linear relationship between 
score and VBAC. From 57.8% 
for scores 0-2 to 97% for 
scores 9-11. 
P=<0.05 
for all 
groups 
29 
Abbreviations: BS=Bishops Score, IOL=Induction of Labour, CS=Caesarean Section, CPD=Cephalo-pelvic disproportion, FH=Fetal Heart, 
NR=Not Reported 
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Table 5: Detailed information on Closure of primary CS studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: The statistics are presented as they were reported in the original publications. NR=Not Reported 
Trial 
(author 
and date) 
Intervention Sample size and 
comparison group 
Uptake of 
VBAC 
Impact on VBAC success 
rates 
Statistical 
values 
Chapman et 
al 1997 
Double vs single 
layer closure 
145 women  
 70 single layer 
 75 double layer 
NA No difference – 
56% - VBAC with single layer 
64% - VBAC with double 
layer 
NR 
Gyamfi et 
al. 2006 
Double vs single 
layer closure 
948 women attempting 
VBAC with previous: 
 35 single layer 
 913 double layer 
NA No difference –  
74% - VBAC with single layer 
77% - VBAC with double 
layer 
P=0.685 
Durnwald 
and Mercer 
2003 
Double vs single 
layer closure 
768 women attempting 
VBAC with previous: 
 267 single layer 
 501 double layer 
NA No difference – 
68% - VBAC with single layer 
65% - VBAC with double 
layer 
NR 
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Table 6: Detailed information on Epidural analgesia / anaesthesia study 
 
 
 
 
 
 
 
 
Note: The statistics are presented as they were reported in the original publications. NR=Not Reported 
 
Trial 
(author 
and date) 
Intervention Sample size and 
comparison group 
Uptake of 
VBAC 
Impact on VBAC success 
rates 
Statistical 
values 
Stovall et 
al. 1987 
EDB in labour 272 women 
 153 had an Epidural 
 119 did not 
NA 85.7% - VBAC without EDB 
74.5% - VBAC with EDB 
NR 
